These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 9070487)
1. Activation of the K-ras oncogene in colorectal neoplasms is associated with decreased apoptosis. Ward RL; Todd AV; Santiago F; O'Connor T; Hawkins NJ Cancer; 1997 Mar; 79(6):1106-13. PubMed ID: 9070487 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa. Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348 [TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene. Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045 [TBL] [Abstract][Full Text] [Related]
4. Laterally spreading type of colorectal adenoma exhibits a unique methylation phenotype and K-ras mutations. Hiraoka S; Kato J; Tatsukawa M; Harada K; Fujita H; Morikawa T; Shiraha H; Shiratori Y Gastroenterology; 2006 Aug; 131(2):379-89. PubMed ID: 16890591 [TBL] [Abstract][Full Text] [Related]
5. Natural history of colorectal nonpolypoid adenomas: a prospective colonoscopic study and relation with cell kinetics and K-ras mutations. Watari J; Saitoh Y; Obara T; Fujiya M; Maemoto A; Ayabe T; Ashida T; Yokota K; Orii Y; Kohgo Y Am J Gastroenterol; 2002 Aug; 97(8):2109-15. PubMed ID: 12190185 [TBL] [Abstract][Full Text] [Related]
6. CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation. Kim H; Yang XL; Rosada C; Hamilton SR; August JT Arch Biochem Biophys; 1994 May; 310(2):504-7. PubMed ID: 7513984 [TBL] [Abstract][Full Text] [Related]
7. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas. Soda G; Antonaci A; Bosco D; Nardoni S; Melis M J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183 [TBL] [Abstract][Full Text] [Related]
8. Relationship between cyclooxygenase-2 expression and K-ras gene mutation in colorectal adenomas. Fujita M; Fukui H; Kusaka T; Morita K; Fujii S; Ueda Y; Chiba T; Sakamoto C; Kawamata H; Fujimori T J Gastroenterol Hepatol; 2000 Nov; 15(11):1277-81. PubMed ID: 11129221 [TBL] [Abstract][Full Text] [Related]
9. Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of vater. Matsubayashi H; Watanabe H; Yamaguchi T; Ajioka Y; Nishikura K; Kijima H; Saito T Cancer; 1999 Aug; 86(4):596-607. PubMed ID: 10440687 [TBL] [Abstract][Full Text] [Related]
10. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients. Zhu D; Keohavong P; Finkelstein SD; Swalsky P; Bakker A; Weissfeld J; Srivastava S; Whiteside TL Cancer Res; 1997 Jun; 57(12):2485-92. PubMed ID: 9192830 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers. Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283 [TBL] [Abstract][Full Text] [Related]
12. [Expression of p53 and bcl-2 in colorectal adenomas and carcinomas]. Sundblad AS; Chumbita RL; Zoppi JA Medicina (B Aires); 1997; 57(6):662-6. PubMed ID: 9674186 [TBL] [Abstract][Full Text] [Related]
13. Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas. Minamoto T; Sawaguchi K; Mai M; Yamashita N; Sugimura T; Esumi H Cancer Res; 1994 Jun; 54(11):2841-4. PubMed ID: 8187064 [TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum. Mosnier JF; Perret AG; Vindimian M; Dumollard JM; Balique JG; Perpoint B; Boucheron S Arch Pathol Lab Med; 1996 Jul; 120(7):654-9. PubMed ID: 8757470 [TBL] [Abstract][Full Text] [Related]
15. K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis. Chaubert P; Benhattar J; Saraga E; Costa J Am J Pathol; 1994 Apr; 144(4):767-75. PubMed ID: 8160776 [TBL] [Abstract][Full Text] [Related]
16. [Cell kinetics of colorectal tumors with assessment by K-ras mutation and PCNA labeling index]. Tanaka M; Omura K; Ishida F; Watanabe Y Nihon Geka Gakkai Zasshi; 1993 Dec; 94(12):1249-55. PubMed ID: 7903793 [TBL] [Abstract][Full Text] [Related]
17. Molecular changes in the Ki-ras and APC genes in colorectal adenomas and carcinomas arising in the same patient. Zauber NP; Sabbath-Solitare M; Marotta SP; Zauber AG; Bishop DT J Pathol; 2001 Mar; 193(3):303-9. PubMed ID: 11241408 [TBL] [Abstract][Full Text] [Related]
18. High-degree tumor budding and podia-formation in sporadic colorectal carcinomas with K-ras gene mutations. Prall F; Ostwald C Hum Pathol; 2007 Nov; 38(11):1696-702. PubMed ID: 17707462 [TBL] [Abstract][Full Text] [Related]
19. Programmed cell death in colorectal carcinogenesis. Valentini AM; Caruso ML; Armentano R; Pirrelli M; Rizzi E; Lapenna F; Renna L Anticancer Res; 1999; 19(4B):3019-24. PubMed ID: 10652586 [TBL] [Abstract][Full Text] [Related]
20. Loss of p21WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers. Sinicrope FA; Roddey G; Lemoine M; Ruan S; Stephens LC; Frazier ML; Shen Y; Zhang W Clin Cancer Res; 1998 May; 4(5):1251-61. PubMed ID: 9607584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]